Inhaler
Latest Novartis AG Patents:
- Compounds and compositions for the treatment of coronaviral related diseases
- TRISPECIFIC BINDING MOLECULES AGAINST TUMOR-ASSOCIATED ANTIGENS AND USES THEREOF
- Treatment for lupus nephritis using anti-BAFFR antibodies
- Anti-IgE antibody therapy for multiple food allergies
- Glue degraders and methods of use thereof
Description
The broken lines shown in
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D656606
Type: Grant
Filed: Jun 21, 2011
Date of Patent: Mar 27, 2012
Assignee: Novartis AG (Basel)
Inventors: John Palmer-Felgate (Horsham), Steven Dudley (Horsham), Shimi Barr (Randwick)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Design IP
Application Number: 29/394,724
Type: Grant
Filed: Jun 21, 2011
Date of Patent: Mar 27, 2012
Assignee: Novartis AG (Basel)
Inventors: John Palmer-Felgate (Horsham), Steven Dudley (Horsham), Shimi Barr (Randwick)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Design IP
Application Number: 29/394,724
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)